Aenova

Sector Healthcare
Location Frankfurt
Date acquired 2006
Transaction size Not disclosed

A global leader in the pharmaceutical and healthcare industries


Under Bridgepoint ownership the company became a key partner for many of Europe's leading pharmaceutical companies. In August 2012 Aenova was acquired by BC Partners for an undisclosed sum.

To learn more about the company, please click here.

Aenova is the company formed by the merger of two separate investments made by Bridgepoint: Swiss Caps, Europe’s No 2 contract soft capsule manufacturer of vitamins, minerals, supplements and pharma products, and Dragenopharm, a German contract manufacturer for the generic prescription drugs market.

Founded in 2006, Aenova is one of the leading contract tablet manufacturers in Europe for prescription and OTC drugs and nutritional supplements and is a leading producer of generic drugs. Combining both businesses created the opportunity to improve manufacturing efficiency, and through sharing technological know-how and IP, accelerate both product development and expansion of its customer base.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.